Currently Viewing:
Newsroom

AJMC® in the Press, January 10, 2020

AJMC Staff
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
A broadcast by WTAJ referenced a June 2019 contributor post published in The American Journal of Managed Care® (AJMC®). The contributor article, titled “The Deadly Costs of Insulin,” details the significant price increases of insulin treatment, from $14 for 1 vial in 2001 to $275 in 2019.

Philly Voice’s piece, “Men with testicular cancer may only need one round of chemo, study says,” cited an article published on AJMC® titled, “When Less Is More: Halving Chemo Keeps Testicular Cancer at Bay, Study Finds.” The article outlined findings from a study stating that young men who undergo chemotherapy after surgery for testicular cancer may live with side effects for decades.

Dark Daily featured an April 2019 article of AJMC® titled, “As DTC Genetic Testing Grows Among Consumers, Insurers Are Beginning to Get on Board.” The article stated that by 2021, 100 million people will have used a direct-to-consumer genetic test, indicating its growing popularity among healthcare providers and consumers.

A September 2019 article on AJMC® titled, “Physician Shortage Likely to Impact OB/GYN Workforce in Coming Years,” was spotlighted by MedCity News, which reported that a women’s health startup providing care by blending technology and physical clinics has pulled in $45 million to support growth.

Related Articles

Genomic Changes Ensure Chemotherapy Response in Testicular Cancer
Medicaid Expansion Led to Earlier Stage at Diagnosis of Testicular Cancer
When Less Is More: Halving Chemo Keeps Testicular Cancer at Bay, Study Finds
 
Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up